C
Harmony Biosciences Holdings, Inc. HRMY
$38.05 $0.882.37% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 39.78M 45.56M 49.48M 46.09M 11.59M
Total Depreciation and Amortization 5.97M 5.97M 5.97M 5.97M 6.05M
Total Amortization of Deferred Charges 163.00K 166.00K 169.00K 175.00K 176.00K
Total Other Non-Cash Items 19.92M 8.16M 4.13M 6.56M 39.31M
Change in Net Operating Assets 13.50M -25.86M 15.82M 11.70M -14.51M
Cash from Operations 79.33M 33.99M 75.56M 70.50M 42.62M
Capital Expenditure -4.00K -128.00K -513.00K -3.00K -632.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- 0.00 0.00 -33.07M
Divestitures -- -- -- -- --
Other Investing Activities -19.59M 2.49M -6.67M 748.00K -21.16M
Cash from Investing -19.59M 2.36M -7.19M 745.00K -54.86M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -3.75M -3.75M -3.75M -3.75M -3.75M
Issuance of Common Stock 2.10M 4.71M 3.24M 2.58M 573.00K
Repurchase of Common Stock -1.03M -1.31M -2.23M 0.00 -269.00K
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -2.69M -352.00K -2.74M -1.18M -3.45M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 57.05M 36.00M 65.63M 70.07M -15.69M